Page last updated: 2024-11-03

procainamide and Lupus Erythematosus, Cutaneous, Subacute

procainamide has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 3 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, Y1
Sawalha, AH1
Vedove, CD1
Del Giglio, M1
Schena, D1
Girolomoni, G1
Marzano, AV1
Vezzoli, P1
Crosti, C1

Reviews

3 reviews available for procainamide and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Drug-induced lupus erythematosus: an update on drugs and mechanisms.
    Current opinion in rheumatology, 2018, Volume: 30, Issue:5

    Topics: Autoimmunity; Genetic Predisposition to Disease; Humans; Hydralazine; Immunologic Factors; Lupus Ery

2018
Drug-induced lupus erythematosus.
    Archives of dermatological research, 2009, Volume: 301, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Antibodies; Antifungal Ag

2009
Drug-induced lupus: an update on its dermatologic aspects.
    Lupus, 2009, Volume: 18, Issue:11

    Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antihypertensive Agents; Antitubercular Agents; Autoa

2009